# Alex M. Chen

> Alex M. Chen, Ph.D., is the co-founder, chairman and CEO of Crystal Pharmatech and Crystal Group, and CEO of Crystal Bio Solutions. A chemistry graduate of Peking University and Rutgers University, he spent eight years at Merck before co-founding Crystal Pharmatech in Suzhou in 2010. His work has expanded from solid-state research into a group spanning small-molecule development, biologics analytical services and nucleic acid technologies.

- **Role:** Co-founder, Chairman & CEO at Crystal Group and Crystal Pharmatech; CEO at Crystal Bio Solutions
- **Organizations:** Crystal Group, Crystal Pharmatech, Crystal Bio Solutions, Merck
- **Education:** B.S. in Chemistry, Peking University, Ph.D. in Chemistry, Rutgers University
- **Known for:** Co-founded Crystal Pharmatech in 2010 and developed a business operating across the United States, Canada and China., Led Crystal Pharmatech as it expanded from solid-state research into formulation development and manufacturing., Leads Crystal Bio Solutions alongside the parent group.

## Career timeline

- **Before 2010** — Worked for eight years at Merck Research Laboratories and Merck Manufacturing Division.
- **2010** — Co-founded Crystal Pharmatech with Yanfeng Zhang and Robert Wenslow in BioBAY, Suzhou Industrial Park, China.
- **2013** — Crystal Pharmatech expanded its research space and its presence in New Jersey and Suzhou.
- **2015** — Crystal Pharmatech raised $10 million in Series A financing.
- **2018** — Crystal Pharmatech raised $14.5 million in Series B financing and established a Toronto formulation development lab through Candoo Pharmatech.
- **2021** — Crystal Formulation Services broadened the group’s formulation and manufacturing work.
- **2022** — The group established a biologics analytical laboratory in New Jersey.
- **2024** — The New Jersey biologics analytical laboratory spun out as Crystal Bio.
- **2025** — As CEO of Crystal Bio Solutions and Crystal Pharmatech, welcomed Lorin Roskos and the launch of quantitative clinical pharmacology services.
- **2026** — Announced expanded collaboration with ELDICO Scientific and a shared Crystal Group brand identity.

## Achievements

- Co-founded Crystal Pharmatech in 2010 and developed a business operating across the United States, Canada and China.
- Led Crystal Pharmatech as it expanded from solid-state research into formulation development and manufacturing.
- Leads Crystal Bio Solutions alongside the parent group.

## Latest updates

- **2026-06** — The group announced a common Crystal Group identity for Crystal Pharmatech, Crystal Bio Solutions and Crystal NAX; Chen was identified as co-founder, chairman and CEO of Crystal Group.
- **2026-04** — Crystal Pharmatech announced an expanded ELDICO Scientific collaboration and plans for an ED-1 MicroED platform at its Suzhou R&D site.
- **2026-01** — Crystal Bio Solutions announced Allan Cortes as head of West Coast business development; Chen was identified as CEO of both CBS and Crystal Pharmatech.
- **2025-09** — Crystal Bio Solutions appointed Lorin Roskos and launched quantitative clinical pharmacology services.

## Links

- Website: https://www.crystalpharmatech.com/
- LinkedIn: https://www.linkedin.com/in/crystalpharmatech

---

Profile page: https://yespress.io/alex-m-chen
Published by YesPress — https://yespress.io
Last updated: 2026-10-22